Fortis Healthcare Ltd. announced its acquisition of a 31.52% stake in Agilus Diagnostics Ltd. from private equity investors, along with plans to raise funds through issuing Non-Convertible Debentures and amendments to its Articles of Association to comply with regulatory requirements.